CANNAINVESTOR Magazine U.S. Privately Held August 2018 | Page 159

159

CIM: Can you provide some color on your five divisions which include: research, indoor farming, extraction, drug delivery, and the vertical integrated license facility?

aiso: We have two main areas in iaso; the one that does not touch the plant and focuses on the development of: IP, SOP’s, technology, and processes in tissue culture propagation, controlled & precision agriculture, full spectrum extraction, and drug delivery. Then we have the side of the business that does touch the plant which is our vertically integrated licenses for cultivation, production, dispensary and research in Puerto Rico. This operation gives us the ability to provide actual feedback to our development business.

CIM: What is your core business? With so many verticals, does this distract you from your core business? What are the advantages to having so many verticals?

aiso: We see the industry as a continuous process of four essential pillars that embrace the foundation of a system that can provide quality, efficacy and safety into their products and be able to repeat that in a consistent manner. For this reason, all our verticals work in synergy and towards the same goal; each complements the other.

CIM: What is your core business? With so many verticals, does this distract you from your core business? What are the advantages to having so many verticals?

aiso: We see the industry as a continuous process of four essential pillars that embrace the foundation of a system that can provide quality, efficacy and safety into their products and be able to repeat that in a consistent manner. For this reason, all our verticals

work in synergy and towards the same goal; each

complements the other.